TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 2 filers reported holding TRILLIUM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $26,519,000 | +7185.4% | 1,510,226 | +3921.4% | 0.00% | – |
| Q2 2021 | $364,000 | -64.1% | 37,555 | -85.1% | 0.00% | – |
| Q1 2020 | $1,015,000 | +3174.2% | 251,272 | +4802.9% | 0.00% | – |
| Q2 2018 | $31,000 | -18.4% | 5,125 | -3.2% | 0.00% | – |
| Q1 2018 | $38,000 | +40.7% | 5,293 | +10.3% | 0.00% | – |
| Q4 2016 | $27,000 | -15.6% | 4,800 | +36.9% | 0.00% | – |
| Q1 2016 | $32,000 | – | 3,505 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 4,040,000 | $59,428,000 | 8.74% |
| Fairmount Funds Management LLC | 1,478,181 | $21,744,000 | 7.78% |
| COMMODORE CAPITAL LP | 852,871 | $12,546,000 | 6.82% |
| Ghost Tree Capital, LLC | 1,950,000 | $28,685,000 | 6.39% |
| Endurant Capital Management LP | 655,741 | $9,646,000 | 3.48% |
| FRAZIER MANAGEMENT LLC | 3,053,107 | $44,879,000 | 3.46% |
| ACUTA CAPITAL PARTNERS, LLC | 803,000 | $11,812,000 | 3.21% |
| NEA Management Company, LLC | 5,736,363 | $84,382,000 | 2.23% |
| Tri Locum Partners LP | 296,838 | $4,366,000 | 1.59% |
| Avidity Partners Management LP | 3,185,200 | $46,854,000 | 1.52% |